In 2026, the application of precision medicine to the 3D bioprinting of a bionic pancreas focuses on eliminating immune rejection and maximizing therapeutic efficacy through patient-specific customization. This approach shifts the paradigm from “one-size-fits-all” donor transplants to highly personalized, bioengineered solutions
3D Bioprinting of a Bionic Pancreas
Project: “3D Bioprinting of scaffolds using live pancreatic islets or insulin-producing cells to create a bionic pancreas,” funded by the National Centre for Research and Development under the “Prevention and Treatment of Civilization Diseases” STRATEGMED program.
Implementation period: 01.01.2017 – 30.06.2021.
Total project cost: 24 709 750,00 PLN
NCBR funding: 23 143 024,00 zł
Demo Request
